Edoardo Cignoli : Gilead to Buy Phenex's Liver-Disease Program

Gilead Sciences reached a deal to buy a liver-disease treatment program from privately held biotechnology company Phenex Pharmaceuticals.



via WSJ.com: US Business http://ift.tt/1xPMe6T